408 related articles for article (PubMed ID: 23933312)
21. Two delta opioid receptor subtypes are functional in single ventral tegmental area neurons, and can interact with the mu opioid receptor.
Margolis EB; Fujita W; Devi LA; Fields HL
Neuropharmacology; 2017 Sep; 123():420-432. PubMed ID: 28645621
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
Hammond DL; Wang H; Nakashima N; Basbaum AI
J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
[TBL] [Abstract][Full Text] [Related]
23. Reciprocal opioid-opioid interactions between the ventral tegmental area and nucleus accumbens regions in mediating mu agonist-induced feeding in rats.
Bodnar RJ; Lamonte N; Israel Y; Kandov Y; Ackerman TF; Khaimova E
Peptides; 2005 Apr; 26(4):621-9. PubMed ID: 15752577
[TBL] [Abstract][Full Text] [Related]
24. Adrenergic receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour.
Ikeda H; Moribe S; Sato M; Kotani A; Koshikawa N; Cools AR
Eur J Pharmacol; 2007 Jan; 554(2-3):175-82. PubMed ID: 17113067
[TBL] [Abstract][Full Text] [Related]
25. GABA(A) agents injected into the ventral pallidum differentially affect dopaminergic pivoting and cholinergic circling elicited from the shell of the nucleus accumbens.
Kitamura M; Ikeda H; Koshikawa N; Cools AR
Neuroscience; 2001; 104(1):117-27. PubMed ID: 11311536
[TBL] [Abstract][Full Text] [Related]
26. Implication of dopaminergic projection from the ventral tegmental area to the anterior cingulate cortex in μ-opioid-induced place preference.
Narita M; Matsushima Y; Niikura K; Narita M; Takagi S; Nakahara K; Kurahashi K; Abe M; Saeki M; Asato M; Imai S; Ikeda K; Kuzumaki N; Suzuki T
Addict Biol; 2010 Oct; 15(4):434-47. PubMed ID: 20731628
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological evidence for a 7-benzylidenenaltrexone-preferring opioid receptor mediating the inhibitory actions of peptidic delta- and mu-opioid agonists on neurogenic ion transport in porcine ileal mucosa.
Poonyachoti S; Portoghese PS; Brown DR
J Pharmacol Exp Ther; 2001 May; 297(2):672-9. PubMed ID: 11303057
[TBL] [Abstract][Full Text] [Related]
28. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
Mitrovic I; Napier TC
J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
[TBL] [Abstract][Full Text] [Related]
29. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area.
Latimer LG; Duffy P; Kalivas PW
J Pharmacol Exp Ther; 1987 Apr; 241(1):328-37. PubMed ID: 3033208
[TBL] [Abstract][Full Text] [Related]
30. Opioidergic modulation of excitability of rat trigeminal root ganglion neuron projections to the superficial layer of cervical dorsal horn.
Takeda M; Tanimoto T; Ikeda M; Kadoi J; Nasu M; Matsumoto S
Neuroscience; 2004; 125(4):995-1008. PubMed ID: 15120859
[TBL] [Abstract][Full Text] [Related]
31. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
32. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
[TBL] [Abstract][Full Text] [Related]
33. Regional and cell-type-specific effects of DAMGO on striatal D1 and D2 dopamine receptor-expressing medium-sized spiny neurons.
Ma YY; Cepeda C; Chatta P; Franklin L; Evans CJ; Levine MS
ASN Neuro; 2012 Mar; 4(2):. PubMed ID: 22273000
[TBL] [Abstract][Full Text] [Related]
34. GABAA and GABAB receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour.
Akiyama G; Ikeda H; Matsuzaki S; Sato M; Moribe S; Koshikawa N; Cools AR
Neuropharmacology; 2004 Jun; 46(8):1082-8. PubMed ID: 15111014
[TBL] [Abstract][Full Text] [Related]
35. Supraspinal delta- and mu-opioid receptors mediate gastric mucosal protection in the rat.
Gyires K; Rónai AZ
J Pharmacol Exp Ther; 2001 Jun; 297(3):1010-5. PubMed ID: 11356923
[TBL] [Abstract][Full Text] [Related]
36. A bi-directional mu-opioid-opioid connection between the nucleus of the accumbens shell and the central nucleus of the amygdala in the rat.
Kim EM; Quinn JG; Levine AS; O'Hare E
Brain Res; 2004 Dec; 1029(1):135-9. PubMed ID: 15533326
[TBL] [Abstract][Full Text] [Related]
37. Role of AMPA and NMDA receptors in the nucleus accumbens shell in turning behaviour of rats: interaction with dopamine receptors.
Ikeda H; Akiyama G; Fujii Y; Minowa R; Koshikawa N; Cools AR
Neuropharmacology; 2003 Jan; 44(1):81-7. PubMed ID: 12559124
[TBL] [Abstract][Full Text] [Related]
38. Behavioral and neurochemical effects of opioids in the paramedian midbrain tegmentum including the median raphe nucleus and ventral tegmental area.
Klitenick MA; Wirtshafter D
J Pharmacol Exp Ther; 1995 Apr; 273(1):327-36. PubMed ID: 7714785
[TBL] [Abstract][Full Text] [Related]
39. μ-Opioid receptors in the nucleus accumbens shell region mediate the effects of amphetamine on inhibitory control but not impulsive choice.
Wiskerke J; Schetters D; van Es IE; van Mourik Y; den Hollander BR; Schoffelmeer AN; Pattij T
J Neurosci; 2011 Jan; 31(1):262-72. PubMed ID: 21209211
[TBL] [Abstract][Full Text] [Related]
40. Systemic morphine-induced Fos protein in the rat striatum and nucleus accumbens is regulated by mu opioid receptors in the substantia nigra and ventral tegmental area.
Bontempi B; Sharp FR
J Neurosci; 1997 Nov; 17(21):8596-612. PubMed ID: 9334431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
